GlassScriptPhysician profile
Joel M Stewart
NPI 1447293584
$4,015.91
in general payments reported to CMS, 2019-2025
21 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Plastic Surgery Within The Head and Neck provider received nationally (typical 2025 total: $300).
See the full distribution for Plastic Surgery Within the Head and Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $49.12 · 2021: $2,206 · 2022: $442 · 2023: $725 · 2024: $94.02 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936 · Consulting Fee: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.35 |
| Consulting Fee | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,282.84 | 2020-2022 | |
| Abbvie INC. | $424.83 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm, Strattice Reconstructive Tissue Matrix Bps |
| Mentor Worldwide LLC | $263.00 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Medtronic, INC. | $214.00 | 2021-2023 | Surgipro Ll, Merocel |
| Comsort, INC | $150.00 | 2019 | |
| Integra Lifesciences Corporation | $118.50 | 2020-2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $106.49 | 2021 | |
| Polynovo North America LLC | $93.02 | 2023-2025 | Novosorb Btm |
| Tela Bio, INC. | $77.93 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $63.59 | 2019 | |
| Stryker Corporation | $43.16 | 2023 | Spy-Phi System |
| Motiva USA, LLC | $39.99 | 2025 | |
| Misonix INC | $27.75 | 2019 | |
| Trevena, INC. | $15.21 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.09 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $14.97 | 2019 | |
| Amgen INC. | $14.95 | 2019 | |
| Galderma Laboratories, L.P. | $13.20 | 2024 | Dysport |
| Eisai INC. | $12.92 | 2019 | |
| Coopersurgical, INC. | $12.85 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.